EU HTA Strategy Digest No.2
Orphan drug JCA - Staying ahead without a crystal ball
How to keep up with the challenges for my orphan drug JCA in 2028.
EU HTA Strategy Digest No.1
Suddenly it's JCA! - How to prepare for my company's unexpected first JCA.
Exclusive download
You can download the detailed document with information on possible fields of action free of charge here. Please enter your contact details in the form. After having confirmed these, you will immediately receive the link to the first issue.
Suddenly it's JCA!
How to prepare for my company's unexpected first JCA.
EU HTA: European Health Technology Assessment (JCA)
Achieve planning security: With us you can align your projects and your resource planning comprehensively and at an early stage on EU HTA and its implications for market access.
EU-HTA: Joint Scientific Consultation (JSC)
to the top